Clinical Trials Logo

Clinical Trial Summary

The study evaluates the safety, tolerability, and efficacy of DMT210 Gel, 5% when applied twice daily for 12 weeks in adult patients with moderate to severe acne rosacea. Half of participants will receive DMT210 Gel while the other half will receive vehicle control.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT03003104
Study type Interventional
Source Dermata Therapeutics
Status Completed
Phase Phase 2
Start date January 2017
Completion date August 30, 2017

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03064438 - Efficacy of ACU-D1 in the Treatment of Acne Rosacea Phase 2
Recruiting NCT02270411 - Inflammatory Cells From Various Pathologies
Completed NCT02147691 - Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study Phase 4
Recruiting NCT04214483 - A Pilot Study to Explore the Role of Gut Flora in Acne
Completed NCT00041977 - Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea Phase 3
Completed NCT00580723 - Effects of PRK 124 Lotion in Acne Rosacea Phase 1/Phase 2
Completed NCT04555525 - A Pilot Study on the Use of Seysara for Rosacea Phase 4